Compare SPRO & BTOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRO | BTOC |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.7M | 43.6M |
| IPO Year | 2017 | 2024 |
| Metric | SPRO | BTOC |
|---|---|---|
| Price | $2.34 | $0.70 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | 328.9K | ★ 427.5K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $40,549,000.00 | ★ $197,399,541.00 |
| Revenue This Year | N/A | $34.89 |
| Revenue Next Year | N/A | $14.53 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 17.35 |
| 52 Week Low | $0.51 | $0.41 |
| 52 Week High | $3.22 | $5.84 |
| Indicator | SPRO | BTOC |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 63.05 |
| Support Level | $2.26 | $0.56 |
| Resistance Level | $2.39 | $0.68 |
| Average True Range (ATR) | 0.08 | 0.05 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 62.50 | 88.46 |
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.